학술논문
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
Document Type
Artikel
Author
Tam, CS; Opat, S; D'Sa, S; Jurczak, W; Lee, HP; Cull, G; Owen, RG; Marlton, P; Wahlin, BE; Sanz, RG; McCarthy, H; Mulligan, S; Tedeschi, A; Castillo, JJ; Czyz, J; de Larrea, CF; Belada, D; Libby, E; Matous, JV; Motta, M; Siddiqi, T; Tani, M; Trneny, M; Minnema, MC; Buske, C; Leblond, V; Trotman, J; Chan, WY; Schneider, J; Ro, S; Cohen, A; Huang, J; Dimopoulos, M
Source
Blood. 136(18):2038-2050
Subject
Language
English
English
English
ISSN
1528-0020